explore -WSS

explore

author：fashion 2025-09-03 03:21:51 - browse：3412

Illustration of a person holding a phone with apps and small people (patients and doctors) on the screen. -- chronic disease coverage from STAT — Molly Ferguson for STAT

If her neurologist moved to China, Lauren Stiles says she’d follow him there. “There’s so few doctors who do this,” said the New York-based president of patient advocacy group Dysautonomia International.

In her world, informed, experienced specialists — particularly in the autonomic nervous system — are extremely rare. Telehealth can open doors for patients who have been searching for a doctor who understands them. Stiles had to travel hundreds of miles to find an expert at the Cleveland Clinic who could diagnose her (it took two years to figure out she has postural orthostatic tachycardia syndrome, or POTS, and Sjögren’s syndrome). When that last-ditch doctor moved to Virginia, she followed him.

But many times, Stiles has questions that shouldn’t take a dozen-hour road trip to answer. She’d love to call him up and have an appointment over the phone.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Readout LOUD podcast: Biotech layoffs, stock slump, 2024 preview

WSS

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

Ascension's ugly legal battle over care for poor patients in Texas

Eli Lilly, Pfizer, and others want in on the online prescription market

Profiling embryos to choose those with higher IQs is almost a reality

AI generated plenty of interest at JPM but not a lot of trust

Readout Newsletter: BridgeBio, Madrigal, and Silicon Valley Bank

focus

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

focus

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Independent physicians launch a new lobbying group

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Test for long Covid? Researchers find new clue in blood samples

Peter Hotez and the public health issue of online harassment

JPM 2024: Biotech’s most prolific dealmaker sees a rosy 2024

Anesthesiologist group: stop taking Ozempic before surgery

Readout LOUD podcast: Biotech layoffs, stock slump, 2024 preview

Hollywood unions extend contract negotiations for actors

Mayo Clinic partners with supercomputer AI firm Cerebras at JPM

knowledge

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

Biotech venture capitalists face new demands from investors

Humana cuts profit projections as Medicare Advantage costs soar

Prior authorization will have to move faster under new Biden rule

Stories you might have missed in 2023: health, science, medicine

How digital therapeutics firms are pivoting after Pear's bankruptcy

entertainment

hotspot

Wikipedia

knowledge